                         SEQUENCE LISTING

<110>  LIFESEARCH
       INSERM
       UNIVERSIT PAUL SABATIER TOULOUSE III
 
<120>  Treatment of hepatic and cardiovascular disorders

<130>  1H320550 0001

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide according the invention

<400>  1

Arg Gly Ala Gly Ser Ile Arg Glu Ala Gly Gly Ala Phe Gly Lys Arg 
1               5                   10                  15      


Glu Gln Ala Glu Glu Glu Arg Tyr Phe Arg Ala Gln Ser Arg Glu 
            20                  25                  30      


<210>  2
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Scramble peptide

<400>  2

Gly Glu Ala Lys Ser Tyr Ala Glu Lys Gly Glu Ala Arg Gly Glu Arg 
1               5                   10                  15      


Gly Thr Lys Gly Glu Phe Arg Ile Phe Lys Arg Glu Ala Thr Asp 
            20                  25                  30      


<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Signature peptide 1

<400>  3

Glu Ala Gly Gly Ala Phe Gly Lys 
1               5               


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Signature peptide

<400>  4

Glu Ala Gly Gly Ala Phe Gly 
1               5           


<210>  5
<211>  81
<212>  PRT
<213>  Homo sapiens

<400>  5

Gly Ser Asp Gln Ser Glu Asn Val Asp Arg Gly Ala Gly Ser Ile Arg 
1               5                   10                  15      


Glu Ala Gly Gly Ala Phe Gly Lys Arg Glu Gln Ala Glu Glu Glu Arg 
            20                  25                  30          


Tyr Phe Arg Ala Gln Ser Arg Glu Gln Leu Ala Ala Leu Lys Lys His 
        35                  40                  45              


His Glu Glu Glu Ile Val His His Lys Lys Glu Ile Glu Arg Leu Gln 
    50                  55                  60                  


Lys Glu Ile Glu Arg His Lys Gln Lys Ile Lys Met Leu Lys His Asp 
65                  70                  75                  80  


Asp 
    


